DE69631330D1 - C-4' modifizierte adenosinkinaseinhibitoren - Google Patents
C-4' modifizierte adenosinkinaseinhibitorenInfo
- Publication number
- DE69631330D1 DE69631330D1 DE69631330T DE69631330T DE69631330D1 DE 69631330 D1 DE69631330 D1 DE 69631330D1 DE 69631330 T DE69631330 T DE 69631330T DE 69631330 T DE69631330 T DE 69631330T DE 69631330 D1 DE69631330 D1 DE 69631330D1
- Authority
- DE
- Germany
- Prior art keywords
- kinase inhibitors
- adenosine kinase
- modified adenosine
- modified
- inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- OOXNYFKPOPJIOT-UHFFFAOYSA-N 5-(3-bromophenyl)-7-(6-morpholin-4-ylpyridin-3-yl)pyrido[2,3-d]pyrimidin-4-amine;dihydrochloride Chemical class Cl.Cl.C=12C(N)=NC=NC2=NC(C=2C=NC(=CC=2)N2CCOCC2)=CC=1C1=CC=CC(Br)=C1 OOXNYFKPOPJIOT-UHFFFAOYSA-N 0.000 title 1
- 239000003121 adenosine kinase inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/14—Pyrrolo-pyrimidine radicals
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US486161 | 1995-06-07 | ||
US08/486,161 US5674998A (en) | 1989-09-15 | 1995-06-07 | C-4' modified adenosine kinase inhibitors |
PCT/US1996/010404 WO1996040705A1 (en) | 1995-06-07 | 1996-06-07 | C-4' modified adenosine kinase inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69631330D1 true DE69631330D1 (de) | 2004-02-19 |
DE69631330T2 DE69631330T2 (de) | 2004-10-28 |
Family
ID=23930844
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69631330T Expired - Fee Related DE69631330T2 (de) | 1995-06-07 | 1996-06-07 | C-4' modifizierte adenosinkinaseinhibitoren |
Country Status (24)
Country | Link |
---|---|
US (1) | US5674998A (de) |
EP (1) | EP0832091B1 (de) |
JP (1) | JPH11507387A (de) |
KR (1) | KR19990022740A (de) |
CN (1) | CN1190401A (de) |
AP (1) | AP9701165A0 (de) |
AT (1) | ATE257841T1 (de) |
AU (1) | AU6178396A (de) |
BG (1) | BG102163A (de) |
BR (1) | BR9609013A (de) |
CA (1) | CA2220642A1 (de) |
CZ (1) | CZ392797A3 (de) |
DE (1) | DE69631330T2 (de) |
EA (1) | EA199800009A1 (de) |
HU (1) | HUP9802193A3 (de) |
IL (1) | IL122335A0 (de) |
IS (1) | IS4621A (de) |
MX (1) | MX9709859A (de) |
NO (1) | NO975585L (de) |
OA (1) | OA10639A (de) |
PL (1) | PL323904A1 (de) |
SK (1) | SK166097A3 (de) |
TR (1) | TR199701539T1 (de) |
WO (1) | WO1996040705A1 (de) |
Families Citing this family (71)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE159257T1 (de) * | 1994-05-03 | 1997-11-15 | Ciba Geigy Ag | Pyrrolopyrimidinderivate mit antiproliferativer wirkung |
IL122855A (en) * | 1995-07-06 | 2004-08-31 | Novartis Ag | History of N-Phenyl (Alkyl) - 7H-Pyrolo [-3,2d] Pyrimidine - 4 Amine, their preparation and pharmaceutical preparations containing them |
US6051578A (en) * | 1996-02-12 | 2000-04-18 | Pfizer Inc. | Pyrazolopyrimidines for treatment of CNS disorders |
US7863444B2 (en) | 1997-03-19 | 2011-01-04 | Abbott Laboratories | 4-aminopyrrolopyrimidines as kinase inhibitors |
US6713474B2 (en) | 1998-09-18 | 2004-03-30 | Abbott Gmbh & Co. Kg | Pyrrolopyrimidines as therapeutic agents |
YU25500A (sh) | 1999-05-11 | 2003-08-29 | Pfizer Products Inc. | Postupak za sintezu analoga nukleozida |
JP2003511454A (ja) * | 1999-08-27 | 2003-03-25 | アイ・シー・エヌ・フアーマシユーテイカルズ・インコーポレイテツド | ピロロ[2,3−d]ピリミジンヌクレオシド類似化合物 |
US6831069B2 (en) | 1999-08-27 | 2004-12-14 | Ribapharm Inc. | Pyrrolo[2,3-d]pyrimidine nucleoside analogs |
US7071199B1 (en) | 1999-09-17 | 2006-07-04 | Abbott Gmbh & Cco. Kg | Kinase inhibitors as therapeutic agents |
SK3812002A3 (en) | 1999-09-17 | 2003-09-11 | Abbott Gmbh & Co Kg | Pyrazolopyrimidines as therapeutic agents |
BR0016415A (pt) * | 1999-12-16 | 2002-12-24 | Alcon Inc | Inibidores de adenosina cinase para o tratamento de dano retinal e de nervo ótico |
WO2001058920A2 (fr) * | 2000-02-10 | 2001-08-16 | Mitsui Chemicals, Inc. | Procede de production selective d'un anomere derive d'un sucre 1-phosphoryle |
US7638496B2 (en) | 2000-02-15 | 2009-12-29 | Valeant Pharmaceuticals North America | Nucleoside analogs with carboxamidine modified monocyclic base |
US7414036B2 (en) * | 2002-01-25 | 2008-08-19 | Muscagen Limited | Compounds useful as A3 adenosine receptor agonists |
AU2002951247A0 (en) | 2002-09-06 | 2002-09-19 | Alchemia Limited | Compounds that interact with kinases |
BRPI0400869B8 (pt) * | 2004-03-02 | 2021-05-25 | Univ Estadual Campinas Unicamp | novos compostos derivados de 4-anilinoquinazolinas com propriedade inibidora de adenosinacinases |
JP2008520744A (ja) | 2004-11-19 | 2008-06-19 | ザ・レジェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア | 抗炎症性ピラゾロピリミジン |
CA2596424C (en) | 2005-02-04 | 2016-03-29 | Millennium Pharmaceuticals, Inc. | Inhibitors of e1 activating enzymes |
US20090118223A1 (en) * | 2005-08-12 | 2009-05-07 | Erion Mark D | Novel 2'-c-methyl and 4'c-methyl nucleoside derivatives |
EP1989206B1 (de) | 2006-02-02 | 2012-07-04 | Millennium Pharmaceuticals, Inc. | Hemmer von e1-aktivierenden enzymen |
EP2557080A1 (de) | 2006-04-04 | 2013-02-13 | The Regents of The University of California | Verfahren zur Identifizierung von PI3-Kinase-Antagonisten |
US20110160232A1 (en) | 2007-10-04 | 2011-06-30 | Pingda Ren | Certain chemical entities and therapeutic uses thereof |
DK2240451T3 (da) | 2008-01-04 | 2017-11-20 | Intellikine Llc | Isoquinolinonderivater substitueret med en purin, der er anvendelig som pi3k-inhibitorer |
US8193182B2 (en) | 2008-01-04 | 2012-06-05 | Intellikine, Inc. | Substituted isoquinolin-1(2H)-ones, and methods of use thereof |
US8993580B2 (en) | 2008-03-14 | 2015-03-31 | Intellikine Llc | Benzothiazole kinase inhibitors and methods of use |
EP2252293B1 (de) | 2008-03-14 | 2018-06-27 | Intellikine, LLC | Kinasehemmer und verwendungsverfahren |
WO2010006072A2 (en) | 2008-07-08 | 2010-01-14 | The Regents Of The University Of California | Mtor modulators and uses thereof |
CA2730106A1 (en) | 2008-07-08 | 2010-01-14 | Intellikine, Inc. | Kinase inhibitors and methods of use |
CA2738429C (en) | 2008-09-26 | 2016-10-25 | Intellikine, Inc. | Heterocyclic kinase inhibitors |
WO2010045542A2 (en) | 2008-10-16 | 2010-04-22 | The Regents Of The University Of California | Fused ring heteroaryl kinase inhibitors |
US8476431B2 (en) | 2008-11-03 | 2013-07-02 | Itellikine LLC | Benzoxazole kinase inhibitors and methods of use |
EP2427195B1 (de) | 2009-05-07 | 2019-05-01 | Intellikine, LLC | Heterocyclische verbindungen und ihre verwendung |
CN102421780A (zh) | 2009-05-14 | 2012-04-18 | 米伦纽姆医药公司 | 氨基磺酸((1s,2s,4r)-4-{4-[(1s)-2,3-二氢-1h-茚-1-基氨基]-7h-吡咯并[2,3-d]嘧啶-7-基}-2-羟基环戊基)甲酯盐酸盐 |
US8927513B2 (en) | 2009-07-07 | 2015-01-06 | Alnylam Pharmaceuticals, Inc. | 5′ phosphate mimics |
WO2011047384A2 (en) | 2009-10-16 | 2011-04-21 | The Regents Of The University Of California | Methods of inhibiting ire1 |
CN103002738A (zh) | 2010-05-21 | 2013-03-27 | 英特利凯恩有限责任公司 | 用于激酶调节的化学化合物、组合物和方法 |
AU2011326427B2 (en) | 2010-11-10 | 2016-01-07 | Infinity Pharmaceuticals Inc. | Heterocyclic compounds and uses thereof |
TWI546305B (zh) | 2011-01-10 | 2016-08-21 | 英菲尼提製藥股份有限公司 | 製備異喹啉酮之方法及異喹啉酮之固體形式 |
JP6130305B2 (ja) | 2011-02-23 | 2017-05-17 | インテリカイン, エルエルシー | キナーゼ阻害剤の組み合わせおよびそれらの使用 |
JP6027610B2 (ja) | 2011-07-19 | 2016-11-16 | インフィニティー ファーマシューティカルズ, インコーポレイテッド | 複素環式化合物及びその使用 |
CN103946226A (zh) | 2011-07-19 | 2014-07-23 | 无限药品股份有限公司 | 杂环化合物及其应用 |
CA2846431A1 (en) | 2011-08-29 | 2013-03-07 | Infinity Pharmaceuticals Inc. | Heterocyclic compounds and uses thereof |
EP2751112B1 (de) | 2011-09-02 | 2019-10-09 | The Regents of The University of California | Substituierte pyrazolo[3,4-d]pyrimidine und ihre verwendung |
CN107459544B (zh) | 2011-12-22 | 2021-03-16 | 詹森生物制药有限公司 | 取代的核苷、核苷酸及其类似物 |
US9441007B2 (en) | 2012-03-21 | 2016-09-13 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
USRE48171E1 (en) | 2012-03-21 | 2020-08-25 | Janssen Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
US8940742B2 (en) | 2012-04-10 | 2015-01-27 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
US8828998B2 (en) | 2012-06-25 | 2014-09-09 | Infinity Pharmaceuticals, Inc. | Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors |
CN104395315B (zh) | 2012-06-29 | 2016-08-17 | 辉瑞大药厂 | 作为LRRK2抑制剂的4-(取代的氨基)-7H-吡咯并〔2,3-d〕嘧啶类 |
CN104995192A (zh) | 2012-09-26 | 2015-10-21 | 加利福尼亚大学董事会 | Ire1的调节 |
US9481667B2 (en) | 2013-03-15 | 2016-11-01 | Infinity Pharmaceuticals, Inc. | Salts and solid forms of isoquinolinones and composition comprising and methods of using the same |
AU2014302715B2 (en) | 2013-06-26 | 2018-12-06 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
WO2015051241A1 (en) | 2013-10-04 | 2015-04-09 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
NZ718430A (en) | 2013-10-04 | 2021-12-24 | Infinity Pharmaceuticals Inc | Heterocyclic compounds and uses thereof |
AU2014331863C1 (en) | 2013-10-11 | 2019-05-16 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
US9695171B2 (en) | 2013-12-17 | 2017-07-04 | Pfizer Inc. | 3,4-disubstituted-1 H-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7H-pyrrolo[2,3-c]pyridazines as LRRK2 inhibitors |
CA2943075C (en) | 2014-03-19 | 2023-02-28 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders |
WO2015160975A2 (en) | 2014-04-16 | 2015-10-22 | Infinity Pharmaceuticals, Inc. | Combination therapies |
WO2016054491A1 (en) | 2014-10-03 | 2016-04-07 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
WO2016066582A1 (en) | 2014-10-28 | 2016-05-06 | Bci Pharma | Nucleoside kinase inhibitors |
WO2017024310A1 (en) | 2015-08-06 | 2017-02-09 | Chimerix, Inc. | Pyrrolopyrimidine nucleosides and analogs thereof useful as antiviral agents |
KR20180058741A (ko) | 2015-09-14 | 2018-06-01 | 인피니티 파마슈티칼스, 인코포레이티드 | 이소퀴놀리논의 고체형, 그의 제조 방법, 이를 포함하는 조성물 및 이를 사용하는 방법 |
EP3350178B1 (de) | 2015-09-14 | 2021-10-20 | Pfizer Inc. | Neuartige imidazo[4,5-c]chinolin- und imidazo[4,5-c][1,5]naphthyridin-derivate als lrrk2-inhibitoren |
WO2017161116A1 (en) | 2016-03-17 | 2017-09-21 | Infinity Pharmaceuticals, Inc. | Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors |
US10919914B2 (en) | 2016-06-08 | 2021-02-16 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
WO2017223422A1 (en) | 2016-06-24 | 2017-12-28 | Infinity Pharmaceuticals, Inc. | Combination therapies |
EP3684771A1 (de) | 2017-09-21 | 2020-07-29 | Chimerix, Inc. | Morphische formen von 4-amino-7-(3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-methyl-7h-pyrrolo[2,3-d]pyrimidin-5-carboxamid und verwendungen davon |
JP2022548820A (ja) | 2019-08-08 | 2022-11-22 | ビー.シー.アイ.ファーマ | プロテインキナーゼ阻害剤としてのイソキノリン誘導体 |
TWI794742B (zh) | 2020-02-18 | 2023-03-01 | 美商基利科學股份有限公司 | 抗病毒化合物 |
CN117120444A (zh) | 2021-04-16 | 2023-11-24 | 吉利德科学公司 | 使用酰胺制备卡巴核苷的方法 |
KR102639275B1 (ko) * | 2021-06-08 | 2024-02-21 | 퓨쳐메디신 주식회사 | 다중 표적 인산화효소 저해 활성을 갖는 뉴클레오사이드 유도체 및 이를 포함하는 암의 예방 및 치료용 약학적 조성물 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4455420A (en) * | 1983-01-13 | 1984-06-19 | Hoffmann-La Roche Inc. | 4-Amino-7-(5-deoxy-beta-D-ribofuranosyl)-5-iodo-7H-pyrrolo[2,3-d] pyrimidine |
DE3712735A1 (de) * | 1987-04-15 | 1988-11-10 | Boehringer Mannheim Gmbh | Neue pyrazolo(3,4-d)pyrimidine, verfahren zu ihrer herstellung und verwendung als arzneimittel |
AU665184B2 (en) * | 1991-01-23 | 1995-12-21 | Gensia, Inc. | Adenosine kinase inhibitors |
CA2100863A1 (en) * | 1991-01-23 | 1992-07-24 | David A. Bullough | Adenosine kinase inhibitors |
EP0684953A4 (de) * | 1993-02-03 | 1999-12-22 | Gensia Inc | Adenosinkinase-inhibitoren die hyxofuranosyl-derivate enthalten. |
IL108523A0 (en) * | 1993-02-03 | 1994-05-30 | Gensia Inc | Pharmaceutical compositions containing adenosine kinase inhibitors for preventing or treating conditions involving inflammatory responses and pain |
US6143749A (en) * | 1995-06-07 | 2000-11-07 | Abbott Laboratories | Heterocyclic substituted cyclopentane compounds |
-
1995
- 1995-06-07 US US08/486,161 patent/US5674998A/en not_active Expired - Fee Related
-
1996
- 1996-06-07 TR TR97/01539T patent/TR199701539T1/xx unknown
- 1996-06-07 WO PCT/US1996/010404 patent/WO1996040705A1/en active IP Right Grant
- 1996-06-07 EA EA199800009A patent/EA199800009A1/ru unknown
- 1996-06-07 CA CA002220642A patent/CA2220642A1/en not_active Abandoned
- 1996-06-07 IL IL12233596A patent/IL122335A0/xx unknown
- 1996-06-07 KR KR1019970709182A patent/KR19990022740A/ko not_active Application Discontinuation
- 1996-06-07 AP APAP/P/1997/001165A patent/AP9701165A0/en unknown
- 1996-06-07 AT AT96919442T patent/ATE257841T1/de not_active IP Right Cessation
- 1996-06-07 AU AU61783/96A patent/AU6178396A/en not_active Abandoned
- 1996-06-07 CN CN96195383A patent/CN1190401A/zh active Pending
- 1996-06-07 SK SK1660-97A patent/SK166097A3/sk unknown
- 1996-06-07 CZ CZ973927A patent/CZ392797A3/cs unknown
- 1996-06-07 DE DE69631330T patent/DE69631330T2/de not_active Expired - Fee Related
- 1996-06-07 HU HU9802193A patent/HUP9802193A3/hu unknown
- 1996-06-07 JP JP9502290A patent/JPH11507387A/ja not_active Ceased
- 1996-06-07 BR BR9609013-8A patent/BR9609013A/pt unknown
- 1996-06-07 PL PL96323904A patent/PL323904A1/xx unknown
- 1996-06-07 EP EP96919442A patent/EP0832091B1/de not_active Expired - Lifetime
-
1997
- 1997-11-26 IS IS4621A patent/IS4621A/is unknown
- 1997-12-03 OA OA70150A patent/OA10639A/en unknown
- 1997-12-03 NO NO975585A patent/NO975585L/no unknown
- 1997-12-08 MX MX9709859A patent/MX9709859A/es unknown
-
1998
- 1998-01-07 BG BG102163A patent/BG102163A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
KR19990022740A (ko) | 1999-03-25 |
EP0832091A1 (de) | 1998-04-01 |
WO1996040705A1 (en) | 1996-12-19 |
OA10639A (en) | 2002-09-17 |
HUP9802193A2 (hu) | 1999-05-28 |
EP0832091B1 (de) | 2004-01-14 |
DE69631330T2 (de) | 2004-10-28 |
US5674998A (en) | 1997-10-07 |
IS4621A (is) | 1997-11-26 |
CN1190401A (zh) | 1998-08-12 |
BR9609013A (pt) | 1999-12-14 |
CZ392797A3 (cs) | 1999-04-14 |
ATE257841T1 (de) | 2004-01-15 |
AU6178396A (en) | 1996-12-30 |
PL323904A1 (en) | 1998-04-27 |
CA2220642A1 (en) | 1996-12-19 |
IL122335A0 (en) | 1998-04-05 |
JPH11507387A (ja) | 1999-06-29 |
AP9701165A0 (en) | 1998-01-31 |
TR199701539T1 (xx) | 1998-04-21 |
HUP9802193A3 (en) | 1999-10-28 |
NO975585L (no) | 1998-02-05 |
EA199800009A1 (ru) | 1998-06-25 |
NO975585D0 (no) | 1997-12-03 |
SK166097A3 (en) | 1999-06-11 |
MX9709859A (es) | 1998-08-30 |
BG102163A (en) | 1998-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69631330D1 (de) | C-4' modifizierte adenosinkinaseinhibitoren | |
BR9611724A (pt) | Inibidor de quinase c de proteína | |
NO980290L (no) | 2(4-substituert)benzylamino-2-metylpropanamidderivater | |
DE69618742T2 (de) | Schaltungsanordnung | |
NO961404D0 (no) | 4-indolylpiperazinyl-derivater | |
NO960353D0 (no) | 4-aminobenzoylguanidinderivater | |
NO960392D0 (no) | 4-merkaptobenzoylguanidinderivater | |
DE69619622D1 (de) | Schaltungsanordnung | |
FI1943U1 (fi) | Bomsystem till skogmaskin | |
DE29510462U1 (de) | Fertilitäts-Hemmer | |
FI953861A0 (fi) | Tillaeggsanordning till saekerhetslaos i doerrars innerkanter | |
KR960030103U (ko) | 움직이지않는 매리야스 | |
FI2002U1 (fi) | Haollare till spoestaell | |
FI1863U1 (fi) | Vaeggkonstruktion till timmerhus | |
FI2187U1 (fi) | Hoerndetalj till plaottlaoda | |
FI2196U1 (fi) | Snoestyrningsblad till snoeslunga | |
FI955199A0 (fi) | Anordning till lyftbom | |
FI956132A0 (fi) | Kopplingskrok till skjutarm | |
FI950851A0 (fi) | Mekanism till kraftoeverfoeringsanordning | |
FI951168A0 (fi) | Kraftoeverfoeringsanordning till rotationskolvmotor | |
FI954177A0 (fi) | Tillaeggsanordning till lyfttruck | |
FI954672A0 (fi) | Utbytbar kupolslitdel till en kupolventil | |
FI950473A0 (fi) | Vaeggkonstruktion till timmerhus | |
FI950084A0 (fi) | Instaellbart ryggstoed till patientstol | |
FI955722A0 (fi) | Foerfarande foer datafoermedling till fondon |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: METABASIS THERAPEUTICS,INC.(N.D.GES.D.STAATES DELA |
|
8339 | Ceased/non-payment of the annual fee |